Hypercholesterolemia Tx algorithm Flashcards
Age 0-19 w/o Hx of FH
lifestyle modifications to prevent/reduce ASCVD risk
Age 0-19 w Hx of FH
initiate statin
Age 20-39 w/o family Hx of premature ASCVD
estimate lifetime risk to encourage ASCVD lowering lifestyle mods
Age 20-39 w family Hx of early ASCVD and LDL >=160mg/dL
consider statin
Age 40-75 with LDL 70-189 w/o T2DM and <5% ASCVD risk
lifestyle modifications
<5% = low risk
Age 40-75 with LDL 70-189 w/o T2DM and 5-7.5% ASCVD Risk.
If risk enhancers present consider moderate intensity statin
5-7.5% = borderline risk
Age 40-75 with LDL 70-189 w/o T2DM and 7.5-<20% ASCVD risk
moderate intensity statin
reduce LDL by 30-40%
7.5 - <20 = intermediate risk
Age 40-75 with LDL 70-189 w/o T2DM and >=20 ASCVD risk
statin
reduce LDL by 50% or more
> =20% = high risk
LDL >=190 mg/dL
no risk assessment; high intensity statin
DM and age 40-75
moderate intensity statin
DM and age 40-75
risk assessment to consider high intensity statin
ASCVD Risk enhancer lipid/biomarkers?
persistently elevated TG of >= 175mg/dL
ASCVD Risk enhancers:
ankle brachial index?
<0.9
ASCVD Risk enhancers:
hs-CRP?
> =2.0mg/dL
ASCVD Risk enhancers:
Lp(a) levels?
> 50 mg/dL
ASCVD Risk enhancers:
apoB?
> =130mg/dL